Nov 30, 2007 14:16 CET New HIV viral load assay developed specifically for resource-limited settings joins global procurement consortium
Tag: exavir load
Press Releases
Nov 16, 2007 08:00 CET Funding to lead to improved HIV management in developing world Cavidi announced today that it has signed an agreement with a consortium of American and Swedish investors. The consortium has provided over US$1.0 million of operational funding, and has committed to raising additional funding as necessary. The capital will be used to drive forward Cavidi’s newly adopted three-year business plan.
Jul 23, 2007 14:04 CEST Researchers in Vietnam are using ExaVir™ Load in the first major study of HIV viral load testing the country has conducted. A focal point of the study is to compare the results of monitoring viral load versus CD4 cell count. The researchers predicted that viral load monitoring would help avoid drug resistance – a growing global threat.
News
Feb 29, 2012 17:24 CET Cavidi has moved to a new facility in Uppsala due to a rapid increase in market demand for their ExaVir Load HIV drug monitoring product. The facility is built to suit Cavidi's needs for multiple new R&D projects and production scale up. "The flexible, modular design of the space allows for unlimited future expansion and was the key to site selection" said CEO John Reisky de Dubnic.
Nov 09, 2010 16:03 CET With affordable, effective diagnostic testing, Cavidi is helping physicians provide essential treatment to HIV patients in resource-strapped developing countries.
Blog posts
Jul 23, 2012 12:30 CEST There are around 370,000 new infant infections worldwide each year. A significant number of these children will die if they are not diagnosed early and started on antiretroviral drugs (ARVs). The problem is not the lack of ARVs as much as a lack of proper HIV early infant diagnostics (EID). Recent reports indicate that RT-technology may be an answer to improved access to (EID).
Images
Feb 29, 2012 15:30 CET Cavidi has moved to a new facility in Uppsala due to a rapid increase in market demand for their ExaVir Load HIV drug monitoring product. The facility is built to suit Cavidi's needs for multiple new R&D projects and production scale up. "The flexible, modular design of the space allows for unlimited future expansion and was the key to site selection" said CEO John Reisky de Dubnic.
Feb 11, 2012 14:12 CET While a routine part of HIV management in Western nations, viral load monitoring is rarely practiced in other parts of the world where the test has been considered impractical due to cost and equipment requirements. All that changed with the introduction of ExaVir Load. The ExaVir Load kit is a registered CE-marked IVD product (in vitro diagnostic use).
Feb 11, 2012 14:01 CET While a routine part of HIV management in Western nations, viral load monitoring is rarely practiced in other parts of the world where the test has been considered impractical due to cost and equipment requirements. All that changed with the introduction of ExaVir Load. The ExaVir Load kit is a registered CE-marked IVD product (in vitro diagnostic use).
Videos
Jun 05, 2008 16:14 CEST
Atlanta – CNN broadcasted a feature piece on Cavidi’s ExaVir Load HIV viral load assay. The story centered on Cavidi’s mission to make essential medical diagnostics accessible to patients in every part of the world. Specifically, it tells the story of how the Swedish company designed an HIV viral load assay that can be implemented in resource-limited settings.
Length 2:39
